OncoSec Medical Inc (ONCSQ)

[Titan V]

Gottlieb: FDA working on a proposal for cancer drugs already approved for one indication where approval for a suppl. app., for 2nd indication can sometimes rely on a more targeted data set, like a single-arm study. Guidance coming to clarify circumstances when appropriate.

Gottlieb: FDA working on a proposal for cancer drugs already approved for one indication where approval for a suppl. app., for 2nd indication can sometimes rely on a more targeted data set, like a single-arm study. Guidance coming to clarify circumstances when appropriate.

— Zach Brennan (@ZacharyBrennan) November 30, 2017